Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Isradipine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : National Institute of Neurological Disorders and Stroke | Michael J. Fox Foundation | Parkinson Study Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Isradipine in Early Parkinson Disease
Details : Isradipine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Parkinson Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 20, 2014
Lead Product(s) : Isradipine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : National Institute of Neurological Disorders and Stroke | Michael J. Fox Foundation | Parkinson Study Group
Deal Size : Inapplicable
Deal Type : Inapplicable